Koyfin Home > Directory > Health Care > Apellis Pharmaceuticals Inc > Total Equity

Apellis Pharmaceuticals Inc Total Equity Chart (APLS)

Apellis Pharmaceuticals Inc annual/quarterly Total Equity from 2017 to 2018.
  • Apellis Pharmaceuticals Inc Total Equity for the quarter ending September 09, 2018 was $196m a 23.99% increase of 47m year over year
  • Apellis Pharmaceuticals Inc Total Equity for the last 12 months ending September 09, 2018 was $196m a 23.99% increase of 47m year over year
  • Apellis Pharmaceuticals Inc Annual Total Equity for 2017 was $149m a 84.02% increase of 125m from 2016
  • Apellis Pharmaceuticals Inc Annual Total Equity for 2016 was $24m a -47.00% decrease of -11m from 2015
  • Apellis Pharmaceuticals Inc Annual Total Equity for 2015 was $35m
Other Balance Sheet Metrics:
  • Apellis Pharmaceuticals Inc Total Assets for the quarter ending September 09, 2018 was $239m a 23.84% increase of 57m year over year
  • Apellis Pharmaceuticals Inc Other Liabilities for the quarter ending December 12, 2018 was $0m a -57.45% decrease of 0m year over year
View Chart On Koyfin

Quarterly APLS Total Equity Data

09/2018$196m
06/2018$230m
03/2018$129m
12/2017$149m
09/2017$12m
06/2017$3m
03/2017$24m

Annual APLS Total Equity Data

2017$149m
2016$24m
2015$35m